Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...

CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding its ...

CLEVELAND, May 06, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation (PNS) in the management of ...

Editor's note: This article has been updated to clarify FDA classification of the Sprint Peripheral Nerve Stinulation system. Cleveland, Ohio-based SPR Therapeutics announced today that it has ...

Philadelphia, PA, Oct. 30, 2017 (GLOBE NEWSWIRE) -- MossRehab, one of the country’s leading rehabilitation institutes in Elkins Park, Pa, (and part of Einstein Healthcare Network) is now offering the ...

As the clinical director of neuromodulation services at MossRehab, Michael Saulino is always looking for new ways to treat nerve pain in patients that don’t involve addictive opioids. “When it comes ...

SPR Therapeutics Inc., a Cleveland medical device company that's developed a neurostimulation platform for pain management, has announced the results of a study of its SPRINT Peripheral Nerve ...

Medical device company SPR Therapeutics makes a neuromodulation system in Minnesota that can treat pain in a person's limbs — even limbs that were amputated long ago. Treating phantom-limb pain is ...

CLEVELAND, July 07, 2025 (GLOBE NEWSWIRE) -- Recently, ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS (SPRINT PNS), offering evidence-based best practice ...

CLEVELAND, Sept. 21, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics shared data on the use of peripheral nerve stimulation (PNS) to deliver pain relief for patients suffering from axial neck pain at the ...